Skip to content
★ Sign in to follow
GP

Gpxmed Stock: price and insider trades · Sweden

ISIN SE0014829255SE·

No insider purchase over the last 90 days. The latest, by Urban Ottosson, was filed 28 Dec 2023.

Gpxmed: what insiders have been doing

Gpxmed is a listed company. Its directors and officers file their transactions with Finansinspektionen. The past year has been quiet: not a single insider filing for Gpxmed. The previous disclosure was published on 23 August 2024.

Our records for Gpxmed go back to 2020, with 3 purchases and 3 sales on the open market in total.

These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.

Insider Decl.
6
Thresholds
n/a
Buy Volume
€13,161
3 ops. · all time
Sell Volume
€8,341
3 ops. · all time
Last declaration on 23 August 2024
Declarations6 total
  • ▼
    Verkställande direktör (VD)Executives
    17,484 SEK24FI-SE
    6,200 shares@ SEK 2.8218.4% of flowAktieISIN SE0014829255FI:csv-65e711f362e5b023a9cc
  • ▼
    Verkställande direktör (VD)Executives
    26,049 SEK25FI-SE
    8,403 shares@ SEK 3.1027.0% of flowAktieISIN SE0014829255FI:csv-968264bfb12042f3c0f2
  • ▼
    Verkställande direktör (VD)Executives
    52,676 SEK27FI-SE
    18,164 shares@ SEK 2.9054.6% of flowAktieISIN SE0014829255FI:csv-84d919363ab494e0cfc6
  • ▲
    StyrelseledamotExecutives
    92,700 SEK15FI-SE
    50,000 shares@ SEK 1.854100.0% of flowAktieISIN SE0014829255FI:csv-a3801352c703e27091db
    Canonical exit: 27 Mar 2024 (T+90)
  • ▲
    Styrelseledamot/suppleantExecutives
    49,997 SEK15FI-SE
    7,812 shares@ SEK 6.40100.0% of flowAktieISIN SE0014829255FI:csv-ab6e5a853309959439a4
    Canonical exit: 31 Dec 2020 (T+90)
  • ▲
    Styrelseledamot/suppleantExecutives
    0FI-SE
    7,812 shares0TeckningsoptionISIN SE0014731006FI:csv-095abf0fc8f163deeeb0
    Canonical exit: 31 Dec 2020 (T+90)

6 of 6 declarations

About Gpxmed

Gpxmed is a company listed on the Stockholm Stock Exchange, specializing in the healthcare sector. It focuses on developing innovative solutions to enhance medical care.